Literature DB >> 903403

Effects of a gamma aminobutyric acid (GABA) derivative, baclofen, on growth hormone and prolactin secretion in man.

F Cavagnini, C Invitti, A Di Landro, L Tenconi, C Maraschini, G Girotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 903403     DOI： 10.1210/jcem-45-3-579

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  14 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  Evidence for a GABAergic control of the exercise-induced rise in GH in man.

Authors:  L Steardo; M Iovino; P Monteleone; M Agrusta; F Orio
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

Review 4.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

5.  Effect of long-term treatment with sodium valproate on gonadotrophin and prolactin secretion in paediatric patients.

Authors:  A Masala; T Meloni; S Alagna; P P Rovasio; S Rassu; G Mele; V Franca
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Impaired growth hormone response to sodium valproate in normal aging.

Authors:  P Monteleone; M Iovino; F Orio; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Dose-related effects of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on growth hormone secretion in normal women.

Authors:  G B Melis; A M Paoletti; V Mais; N M Mastrapasqua; F Strigini; F Fruzzetti; G Guarnieri; M Gambacciani; P Fioretti
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

8.  Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.

Authors:  G Laakmann; M Wittmann; M Gugath; O A Mueller; J Treusch; U Wahlster; G K Stalla
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  The neuro-endocrine impact of 3-hydroxy-diazepam (temazepam) in women.

Authors:  M D Beary; J H Lacey; A V Bhat
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 10.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.